3 results
Approved WMOCompleted
To validate the Nexfin cardiac output monitor for morbidly obese patients undergoing elective surgery with the PiCCO monitor.
Approved WMOCompleted
The objective is to assess the feasibility and safety of the Qvanteq*s bioactive coronary Qstent for treatment of stable coronary artery disease patients with de novo coronary artery stenosis in native vessels.
Approved WMOCompleted
There is no formal research hypothesis for this study. The purpose is to evaluate the effects of dapagliflozin on kidney function (GFR) and the changes from baseline in the ambulatory Blood Pressure. The effects of dapagliflozin on red cell mass and…